UNAIDS sets 90-90-90 target for 2020 to end AIDS by 2030
1 August 2014. Related: Conference reports, Treatment access.
2014
No difference in overall anaemia rate with reduced dose AZT
1 August 2014. Related: Conference reports, Treatment strategies, Treatment access.
Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy
1 August 2014. Related: Conference reports, HIV prevention and transmission.
Cure research at IAS 2014: TILDA measures the reservoir and romidepsin wakes it up
1 August 2014. Related: Conference reports, Cure-related research.
HIV and transgender issues at AIDS 2014
1 August 2014. Related: Conference reports.
Transgender services and clinics: interviews at AIDS 2014 with JoAnne Keatley and Beatriz Grinsztejn
1 August 2014. Related: Conference reports, Treatment advocacy.
Publications launched at AIDS 2014
1 August 2014. Related: Conference reports.
6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne
1 August 2014. Related: Conference reports.
Update on paediatric antiretrovirals
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Is d4T a viable option for children in low-income countries?
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
1 August 2014. Related: Conference reports, Paediatric care.
Rationalising the paediatric antiretroviral formulary in Malawi
1 August 2014. Related: Conference reports, Treatment access, Paediatric care.
Time to first-line failure in the IeDEA cohort
1 August 2014. Related: Conference reports, Paediatric care.
Influence of early ART on antibody detection in children
1 August 2014. Related: Conference reports, Paediatric care.
8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Poor Settings (INTEREST), 5-6 May 2014, Lusaka, Zambia
1 August 2014. Related: Conference reports.
Short-term safety of atazanavir/ritonavir-based second line treatment in Zambia
1 August 2014. Related: Conference reports, Antiretrovirals.
Pregnancy outcomes in Zambia
1 August 2014. Related: Conference reports, Pregnancy.
Uptake of ART is influenced by distance to the health facility in rural Zambia
1 August 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Genotyping using dried blood spots in rural South African setting
1 August 2014. Related: Conference reports, Drug resistance.
Dolutegravir-based single-tablet regimen set for EU approval
1 August 2014. Related: Antiretrovirals.
WHO guidelines for key populations (July 2014): gay men, people who inject drugs, people in prisons, sex workers, transgender people
1 August 2014. Related: Guidelines.
EASL update guidelines for hepatitis C (April 2014)
1 August 2014. Related: Guidelines.
New ARV prescribing guidelines for London (2014)
1 August 2014. Related: Treatment access, Guidelines.
Bone mineral density linked to inflammatory markers in HIV positive people who are ART naïve
1 August 2014. Related: Side effects.
Effects of long-term ART initiated during primary HIV infection on reservoir size
1 August 2014. Related: Cure-related research, Basic science and immunology.
Wrestling with the implications of the Mississippi case
1 August 2014. Related: Paediatric care, Cure-related research.
Molecular events in HIV neutralising antibody development
1 August 2014. Related: Basic science and immunology, Vaccines and microbicides.
US Senate investigate Gilead for sofosbuvir price: potential to bankrupt Federal healthcare and add $300 annually to every American insurance premium for the next five years
1 August 2014. Related: Hepatitis coinfection.
Community reports and briefings
1 August 2014. Related: On the web.
Online journals
1 August 2014. Related: On the web.
Volume 15 Number 7/8 July/August 2014 PDF
1 August 2014. Related: PDFs.
HTB supplement: 2014 Pipeline Report
19 July 2014. Related: Special reports, Pipeline report.
Dedication: Marvin Oscar Shulman
19 July 2014. Related: Pipeline report.
Introduction and executive summary
19 July 2014. Related: Pipeline report.
The antiretroviral pipeline 2014
19 July 2014. Related: Pipeline report, Antiretrovirals.
Fit for purpose: treatment optimisation 2014
19 July 2014. Related: Pipeline report, Fit for purpose, Treatment strategies.
The paediatric antiretroviral pipeline
19 July 2014. Related: Pipeline report, Antiretrovirals, Paediatric care.
Preventive technologies: antiretroviral and vaccine development
19 July 2014. Related: Pipeline report, Antiretrovirals, HIV prevention and transmission, Vaccines and microbicides.
Research toward a cure and immune-based and gene therapies
19 July 2014. Related: Pipeline report, Cure-related research.
Hepatitis C pipeline: BONANZA! The gold rush is under way
19 July 2014. Related: Pipeline report, Hepatitis coinfection.
Global update: hepatitis C treatment activism
19 July 2014. Related: Pipeline report, Treatment access, Hepatitis coinfection.
The tuberculosis diagnostics pipeline
19 July 2014. Related: Pipeline report, TB coinfection.
Tuberculosis drug development hobbles forward
19 July 2014. Related: Pipeline report, TB coinfection.
Playing catch-up: paediatric tuberculosis treatment pipeline
19 July 2014. Related: Pipeline report, Paediatric care, TB coinfection.
The tuberculosis vaccines pipeline
19 July 2014. Related: Pipeline report, TB coinfection.
Acknowledgments
19 July 2014. Related: Pipeline report.
May/June 2014: Volume 15 Number 5/6
27 May 2014. Related: Editorial.
49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014), 9-13 April 2014, London
27 May 2014. Related: Conference reports.
Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed
27 May 2014. Related: Conference reports, Treatment access.
EASL 2014: summary of interferon-free HCV studies with new DAAs
27 May 2014. Related: Conference reports, Other news.
WHO launch treatment guidelines for hepatitis C (2014)
27 May 2014. Related: Conference reports, Guidelines, Hepatitis coinfection.
3rd Joint Conference of BHIVA/BASHH, 1-4 April 2014, Liverpool
27 May 2014. Related: Conference reports.
50% of UK seroconverters start ART within 1.4 years of infection: treating during primary infection should be a patient choice
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
PIVOT study: further analysis from five-year PI/r monotherapy strategy study
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Sexually transmitted HCV in HIV positive and negative gay men
27 May 2014. Related: Conference reports, Hepatitis coinfection.
Annual HCV testing and use of core antigen to reduce costs and increase diagnosis during acute HCV
27 May 2014. Related: Conference reports, Hepatitis coinfection.
HIV positive attitudes to involvement as donors and recipients in organ transplant programmes
27 May 2014. Related: Conference reports.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
27 May 2014. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Early antiretroviral treatment in infants
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Hospitalisation among elite controllers
27 May 2014. Related: Conference reports, Treatment strategies.
Catching up with pathogenesis and cure research from CROI 2014
27 May 2014. Related: Conference reports, Paediatric care, Cure-related research.
No increase death rate in HIV positive people with renal dysfunction receiving tenofovir in Zambia
27 May 2014. Related: Side effects.